Phaseline

Targets › CA7

CA7 (Carbonic anhydrase 7): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 4; Ophthalmology.

Reversible hydration of carbon dioxide. (UniProt, P43166)

Open in Phaseline: the race on CA7, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
University of Colorado, DenverMethazolamide
Carbonic anhydrase VII inhibitor; Carbonic anhydrase I inhibitor; Carbonic anhydrase II inhibitor
CA7, CA1, CA2, CA4Phase 4Glaucoma, Open-Angle–

Conditions

Glaucoma, Open-Angle (1)

Modalities

small molecule (1)

Companies

University of Colorado, Denver (1)

Related targets

CA1 (1) CA2 (1) CA4 (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.